Melatonina Biofarm (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. By activating these receptors, it signals darkness to the body, synchronizes circadian rhythms, and facilitates the transition from wakefulness to sleep.

The appropriate dose of Melatonina Biofarm is determined by a qualified healthcare professional based on the individual’s age, condition, and response. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Melatonina Biofarm.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with antihistamine‑based or benzodiazepine sleep aids, melatonin offers a physiologic approach by mimicking the body’s natural hormone. It generally has a more favorable safety profile, fewer next‑day residual effects, and is not classified as a controlled substance, though efficacy may vary among individuals.

Store Melatonina Biofarm at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain potency throughout its shelf life.

Melatonina Biofarm is taken orally, usually with a glass of water. It is commonly taken 30‑60 minutes before the intended bedtime, but the exact timing and frequency should follow the prescribing clinician’s guidance.

Rare but serious adverse events include severe allergic reactions, marked hypotension, mood disturbances such as depression, and persistent daytime sleepiness. Any unexpected or severe symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin, those taking interacting medications without medical supervision, and patients with uncontrolled severe hepatic or renal disease should avoid using Melatonina Biofarm unless directed by a healthcare professional.